Comments
The Indian drugs regulator is confident about the medicines produced by Ranbaxy that are in circulation in the domestic market.
Drugs Controller General of India G.N. Singh said, “Whatever medicines are placed in the Indian market are safe. Otherwise, they would have been withdrawn.”
He emphasised that this applies not only to medicines manufactured by Ranbaxy but all the drugs being sold in India.
Ranbaxy is in the eye of the storm again after the US Food and Drugs Administration expressed concern over the safety of the drug-major’s medicines on Wednesday and alleged that hair and oil particles were found in samples.
aesha.datta@thehindu.co.in
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.